2020 Symposium Keynote Speaker
Peter Friedmann, MD, MPH, DFASAM, FACP is Chief Research Officer and Endowed Chair for Clinical Research, Baystate Health; Associate Dean for Research & Professor of Medicine at UMass Chan-Baystate; Professor of Population and Quantitative Health Sciences at UMass Chan-Baystate; and, Editor-In-Chief, JSAT. Previously, he was Professor of Medicine & Health Services, Policy & Practice at the Alpert Medical School and School of Public Health of Brown University. He was the founding director of the Center of Innovation in Long-Term Services & Supports at the Providence VA Medical Center & the Brown/Rhode Island Hospital Fellowship in Addiction Medicine. Dr. Friedmann is a primary care internist, addiction medicine clinician, & established substance abuse researcher who has published over 160 peer-reviewed articles on the organization of treatment services, treatment process & outcomes, implementation of evidence-based practices for substance use disorders (SUDs) in medical, specialty addiction and correctional settings and the role of the physicians in the care of patients with SUDs. He has had continuous funding from the National Institute on Drug Abuse (NIDA), National Institute on Alcohol Abuse and Alcoholism and Department of Veterans Affairs since 1996, and was a Robert Wood Johnson Generalist Physician Faculty Scholar. Dr. Friedmann began a two-year term as President of the Massachusetts Society of Addiction Medicine (MASAM) on May 17, 2019. He is past president of the Association for Medical Education and Research in Substance Abuse (AMERSA), and former director on the American Board of Addiction Medicine. As Chief Research Officer and Regional Associate Dean for Research at UMass Chan-Baystate, Dr. Friedmann has responsibility for overseeing and growing the research enterprise at Baystate.